Tocilizumab in systemic lupus erythematosus : data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

収録刊行物

• Arthritis Rheum

  Arthritis Rheum 62 542-552, 2010